Cargando…
The Evaluation of APTT Reagents in Reference Plasma, Recombinant FVIII Products; Kovaltry® and Jivi® Using CWA, Including sTF/7FIX Assay
The FVIII activity in patients treated with several extended half-life FVIII (EHL-FVIII) agents different when various activated partial thromboplastin time (APTT) reagents were used. The present study examined the difference in clot waveform analysis (CWA) findings and FVIII activity when various A...
Autores principales: | Wada, Hideo, Shiraki, Katsuya, Matsumoto, Takeshi, Ohishi, Kohshi, Shimpo, Hideto, Sakano, Yumi, Nishii, Hiroko, Shimaoka, Motomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900842/ https://www.ncbi.nlm.nih.gov/pubmed/33606948 http://dx.doi.org/10.1177/1076029620976913 |
Ejemplares similares
-
Comments to: An Evaluation of Hemostatic Abnormalities in Patients With
Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing
Hemophilia or Inhibitor
por: Matsumoto, Takeshi, et al.
Publicado: (2019) -
Update on the Clot Waveform Analysis
por: Wada, Hideo, et al.
Publicado: (2020) -
Clot Waveform Analysis for Hemostatic Abnormalities
por: Wada, Hideo, et al.
Publicado: (2023) -
Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019
por: Wada, Hideo, et al.
Publicado: (2023) -
Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk
por: Suzuki, Kei, et al.
Publicado: (2019)